G-Protein Coupled Receptors Manufacturers Technological Advancements, Revenue Diversification, Patent Expansions, Cross-border Expansion, Performance Gap Identification, Organizational Growth Plans, Operational Excellence

G-Protein Coupled Receptors Key Players and their Developments

The global G-protein coupled receptors market size is calculated at US$ 3.86 in 2024, grew to US$ 4.06 billion in 2025, and is projected to reach around US$ 6.37 billion by 2034. The market is expanding at a CAGR of 5.14% between 2024 and 2034.

Top Companies in the G-Protein Coupled Receptors Market

• Thermo Fisher Scientific Inc.
• Eurofins Scientific
• QIAGEN
• WuXi AppTec
• Promega Corporation
• Abcam plc
• Merck KGaA
• PerkinElmer Inc.
• Enzo Biochem Inc.
• BD

Recent Developments in the G-Protein Coupled Receptors Market

• In December 2024, Nature published a thorough paper. A novel synthetic receptor created by Stanford researchers can process a wider variety of inputs and generate a wider range of outputs. This invention, known as "Programmable Antigen-gated G protein-coupled Engineered Receptors" (PAGER), is based on G protein-coupled receptors, which are a group of more than 800 proteins found in the human body that activate G-proteins, which are molecular switches inside cells that regulate a variety of essential processes.
• In February 2024, the biotech innovation business Cumulus Oncology is pleased to announce the launch of GIO Therapeutics AG, a Basel, Switzerland-based company. Pharmaceutical development focusing on G protein-coupled receptors (GPCR) is the area of expertise for this recently founded biotech business.